Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.

Background: Cisplatin-based induction chemotherapy plus concurrent chemoradiotherapy in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma has been recommended in the National Comprehensive Cancer Network Guidelines. However, cisplatin is associated with poor patient com...

Descripción completa

Detalles Bibliográficos

Publicado en:	Lancet Oncology Vol. 22; no. 5; pp. 716 - 727
Autores principales:	Lv, Xing, Cao, Xun, Xia, Wei-Xiong, Liu, Kui-Yuan, Qiang, Meng-Yun, Guo, Ling, Qian, Chao-Nan, Cao, Ka-Jia, Mo, Hao-Yuan, Li, Xian-Ming, Li, Zi-Huang, Han, Fei, He, Yu-Xiang, Liu, Yu-Meng, Wu, Shao-Xiong, Bai, Yong-Rui, Ke, Liang-Ru, Qiu, Wen-Ze, Liang, Hu, Liu, Guo-Ying
Formato:	research Journal Article
Publicado:	Elsevier B.V. May2021
Acceso en línea:	Ver este registro en EBSCOhost